BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 17, 2011
View Archived Issues
Novel kinase inhibitors identified at Abraxis BioScience
Read More
Celtic Therapeutics acquires RX-10045 from Resolvyx Pharma
Read More
Gruenenthal claims new bradykinin B1 receptor antagonists
Read More
InSite Vision files IND for ISV-101 for dry eye disease
Read More
Merck & Co. confirms changes to two phase III trials of vorapaxar
Read More
Effects of eritoran tetrasodium in sepsis evaluated by phase II data analyses
Read More
CVA21 and doxorubicin demonstrate synergistic anticancer activity in vivo
Read More
Self-assembling KGF-ELP nanoparticles show promise in wound healing
Read More
Vicept Therapeutics reports phase II data on V-101 in rosacea
Read More
OncoMed begins phase I trial of OMP-59R5 in advanced solid tumors
Read More
Biotie Therapies presents new integrin alpha-2/beta-1 inhibitors
Read More
Chimeric SARS S/influenza M1 VLPs protect mice from SARS
Read More
Lupin divulges new dipeptidyl peptidase 4 inhibitors
Read More
FibroGen commences phase II trial of FG-3019 in IPF
Read More
Threshold Pharma claims new camptothecin derivatives for cancer therapy
Read More
FDA limits amount of acetaminophen in prescription combination products
Read More
Shionogi launches Kapvay in U.S. for ADHD
Read More
Dyax and Sigma-Tau expand agreement to commercialize Kalbitor
Read More
SCV-07 advances in phase IIb trial for prevention of oral mucositis in head and neck cancer
Read More
University of Edinburgh divulges new 11-beta-HSD1 inhibitors
Read More
Excaliard reports data from three phase II trials of EXC-001
Read More
ChemGenex notifies EMA of withdrawal of MAA for Tekinex for Ph+ CML
Read More
Dynavax completes enrollment in phase III Heplisav trial
Read More
Oryzon receives grant to support research of lysine-specific histone demethylase 1A
Read More
FDA extends PDUFA date for Gestiva
Read More
MedImmune begins phase I MEDI-565 trial in gastrointestinal cancers
Read More
